235 related articles for article (PubMed ID: 17276368)
1. HHV-6 and the immune system: mechanisms of immunomodulation and viral escape.
Lusso P
J Clin Virol; 2006 Dec; 37 Suppl 1():S4-10. PubMed ID: 17276368
[TBL] [Abstract][Full Text] [Related]
2. Differential HHV-6A gene expression in T cells and primary human astrocytes based on multi-virus array analysis.
Yao K; Mandel M; Akyani N; Maynard K; Sengamalay N; Fotheringham J; Ghedin E; Kashanchi F; Jacobson S
Glia; 2006 Jun; 53(8):789-98. PubMed ID: 16541415
[TBL] [Abstract][Full Text] [Related]
3. Viral interactions in human lymphoid tissue: Human herpesvirus 7 suppresses the replication of CCR5-tropic human immunodeficiency virus type 1 via CD4 modulation.
Lisco A; Grivel JC; Biancotto A; Vanpouille C; Origgi F; Malnati MS; Schols D; Lusso P; Margolis LB
J Virol; 2007 Jan; 81(2):708-17. PubMed ID: 17065205
[TBL] [Abstract][Full Text] [Related]
4. Specific CD8⁺ T cells recognize human herpesvirus 6B.
Martin LK; Schub A; Dillinger S; Moosmann A
Eur J Immunol; 2012 Nov; 42(11):2901-12. PubMed ID: 22886850
[TBL] [Abstract][Full Text] [Related]
5. Pathogenic effects of human herpesvirus 6 in human lymphoid tissue ex vivo.
Grivel JC; Santoro F; Chen S; Fagá G; Malnati MS; Ito Y; Margolis L; Lusso P
J Virol; 2003 Aug; 77(15):8280-9. PubMed ID: 12857897
[TBL] [Abstract][Full Text] [Related]
6. Distinct effects of human herpesvirus 6 and human herpesvirus 7 on surface molecule expression and function of CD4+ T cells.
Furukawa M; Yasukawa M; Yakushijin Y; Fujita S
J Immunol; 1994 Jun; 152(12):5768-75. PubMed ID: 7911490
[TBL] [Abstract][Full Text] [Related]
7. Role of dendritic cells infected with human herpesvirus 6 in virus transmission to CD4(+) T cells.
Takemoto M; Imasawa T; Yamanishi K; Mori Y
Virology; 2009 Mar; 385(2):294-302. PubMed ID: 19144370
[TBL] [Abstract][Full Text] [Related]
8. The role of MAPK in CD4(+) T cells toll-like receptor 9-mediated signaling following HHV-6 infection.
Chi J; Wang F; Li L; Feng D; Qin J; Xie F; Zhou F; Chen Y; Wang J; Yao K
Virology; 2012 Jan; 422(1):92-8. PubMed ID: 22055432
[TBL] [Abstract][Full Text] [Related]
9. Estimating immunoregulatory gene networks in human herpesvirus type 6-infected T cells.
Takaku T; Ohyashiki JH; Zhang Y; Ohyashiki K
Biochem Biophys Res Commun; 2005 Oct; 336(2):469-77. PubMed ID: 16140273
[TBL] [Abstract][Full Text] [Related]
10. Viral replication-independent blockade of dendritic cell maturation and interleukin-12 production by human herpesvirus 6.
Smith AP; Paolucci C; Di Lullo G; Burastero SE; Santoro F; Lusso P
J Virol; 2005 Mar; 79(5):2807-13. PubMed ID: 15708999
[TBL] [Abstract][Full Text] [Related]
11. Immunomodulation and immunosuppression by human herpesvirus 6A and 6B.
Dagna L; Pritchett JC; Lusso P
Future Virol; 2013 Mar; 8(3):273-287. PubMed ID: 24163703
[TBL] [Abstract][Full Text] [Related]
12. [Human herpesvirus-6 infection induces IL-10 production in monocytes].
Li C; Goodrich JM; Yang X
Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 1998 Jun; 12(2):151-4. PubMed ID: 12515195
[TBL] [Abstract][Full Text] [Related]
13. Activation of human herpesviruses 6 and 7 in patients with chronic fatigue syndrome.
Chapenko S; Krumina A; Kozireva S; Nora Z; Sultanova A; Viksna L; Murovska M
J Clin Virol; 2006 Dec; 37 Suppl 1():S47-51. PubMed ID: 17276369
[TBL] [Abstract][Full Text] [Related]
14. [Immune response to HHV-6 and HHV-7].
Yasukawa M
Nihon Rinsho; 2006 Mar; 64 Suppl 3():415-20. PubMed ID: 16615507
[No Abstract] [Full Text] [Related]
15. Computational simulation of chronic persistent virus infection: factors determining differences in clinical outcome of HHV-6, HIV-1 and HTLV-1 infections including aplastic, hyperplastic and neoplastic responses.
Krueger GR; Brandt ME; Wang G; Buja LM
Anticancer Res; 2004; 24(1):187-97. PubMed ID: 15015596
[TBL] [Abstract][Full Text] [Related]
16. Kinetics of cytokine and chemokine responses in patients with primary human herpesvirus 6 infection.
Yoshikawa T; Kato Y; Ihira M; Nishimura N; Ozaki T; Kumagai T; Asano Y
J Clin Virol; 2011 Jan; 50(1):65-8. PubMed ID: 21035385
[TBL] [Abstract][Full Text] [Related]
17. Human herpesvirus 6A decreases the susceptibility of macrophages to R5 variants of human immunodeficiency virus 1: possible role of RANTES and IL-8.
Csoma E; Deli T; Kónya J; Csernoch L; Beck Z; Gergely L
Virus Res; 2006 Nov; 121(2):161-8. PubMed ID: 16815583
[TBL] [Abstract][Full Text] [Related]
18. NKG2C is a major triggering receptor involved in the V[delta]1 T cell-mediated cytotoxicity against HIV-infected CD4 T cells.
Fausther-Bovendo H; Wauquier N; Cherfils-Vicini J; Cremer I; Debré P; Vieillard V
AIDS; 2008 Jan; 22(2):217-26. PubMed ID: 18097224
[TBL] [Abstract][Full Text] [Related]
19. Dynamics of infection with human herpesvirus-6 in EBV-negative infectious mononucleosis: data acquisition for computer modeling.
Krueger GR; Bertram G; Ramon A; Koch B; Ablashi DV; Brandt ME; Wang G; Buja LM
In Vivo; 2001; 15(5):373-80. PubMed ID: 11695232
[TBL] [Abstract][Full Text] [Related]
20. Highlights from 5th International Conference on HHV-6 and -7.
Komaroff AL; Jacobson S; Ablashi DV; Yamanishi K
Herpes; 2006 Nov; 13(3):81-2. PubMed ID: 17147913
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
